Thirty-five years ago drug manufacturer Merck & Co. invented a groundbreaking treatment for river blindness, a disease that affects millions of people in Africa. The company donated billions of doses and frequently touted its philanthropy, building a narrative about the good a drugmaker can do.
Few people had ever heard of the tropical disease treatment until this year. Now that antiparasitic— ivermectin—is a household name, and the story is well out of Merck’s hands. In the midst of the Covid-19 crisis, anti-vaxxers embraced it as a treatment for the virus despite a lack of scientific evidence to support its use. Merck has recently developed molnupiravir, a Covid treatment the company hopes will soon become a key tool in stemming the pandemic, even though it’s entering a world in which rampant misinformation could undermine the use of new drugs. So the company is now in the odd position of telling the public both that molnupiravir works against Covid and that ivermectin doesn’t.
The pharmaceutical industry hasn’t found effective ways to combat misinformation thus far. Merck took a stab when it became obvious that people were turning to ivermectin—mostly known in the West as a medicine for livestock—as a Covid treatment after lab research showed it could inhibit replication of the virus. Studies in humans didn’t prove it worked.
この記事は Bloomberg Businessweek の December 13, 2021 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Bloomberg Businessweek の December 13, 2021 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Instagram's Founders Say It's Time for a New Social App
The rise of AI and the fall of Twitter could create opportunities for upstarts
Running in Circles
A subscription running shoe program aims to fight footwear waste
What I Learned Working at a Hawaiien Mega-Resort
Nine wild secrets from the staff at Turtle Bay, who have to manage everyone from haughty honeymooners to go-go-dancing golfers.
How Noma Will Blossom In Kyoto
The best restaurant in the world just began its second pop-up in Japan. Here's what's cooking
The Last-Mover Problem
A startup called Sennder is trying to bring an extremely tech-resistant industry into the age of apps
Tick Tock, TikTok
The US thinks the Chinese-owned social media app is a major national security risk. TikTok is running out of ways to avoid a ban
Cleaner Clothing Dye, Made From Bacteria
A UK company produces colors with less water than conventional methods and no toxic chemicals
Pumping Heat in Hamburg
The German port city plans to store hot water underground and bring it up to heat homes in the winter
Sustainability: Calamari's Climate Edge
Squid's ability to flourish in warmer waters makes it fitting for a diet for the changing environment
New Money, New Problems
In Naples, an influx of wealthy is displacing out-of-towners lower-income workers